Finding accredited CPD
Hepatocellular carcinoma (HCC) is a leading cause of cancer deaths both globally and in Australia. Surveillance for HCC in at‐risk populations allows diagnosis at an early stage, when potentially curable. However, most Australians diagnosed with HCC die of the cancer or of liver disease.
In the changing landscape of HCC management, unique challenges may lead to clinical practice variation. As a result, there is a need to identify best practice management of HCC in an Australian context. This consensus statement has been developed for health professionals involved in the care of adult patients with HCC in Australia. It is applicable to specialists, general medical practitioners, nurses, health coordinators and hospital administrators.
This MJA consensus statement shares more.
Authors: John S Lubel, Stuart K Roberts, Simone I Strasser, Alexander J Thompson, Jennifer Philip, Mark Goodwin, Stephen Clarke, Darrell HG Crawford, Miriam T Levy, Nick Shackel
Article Type: Consensus statement
You have to log in to see the content of this module.
Provided by
Accredited by
*Medical Board of Australia’s (MBA)’s revised Registration Standard: Continuing professional development (the Standard)